SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-001022
Filing Date
2012-02-02
Accepted
2012-02-02 16:59:44
Documents
4
Period of Report
2012-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pdl_8k-013112.htm 8-K 51553
2 FORM OF EXCHANGE AGREEMENT ex10-1.htm EX-10.1 48610
3 PRESS RELEASE ex99-1.htm EX-99.1 8944
4 logo.jpg GRAPHIC 2519
  Complete submission text file 0001437749-12-001022.txt   114126
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 12566561
SIC: 2836 Biological Products, (No Diagnostic Substances)